Publications by authors named "J Lemonnier"

Claim this Profile
L
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).
Pascal Pujol, Lise Roca, Alain Lortholary, Christine Lasset, Louise Crivelli, Jérôme Lemonnier

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial.
Frédérique Penault-Llorca, Amelie Lusque, Thomas Filleron, Kevin Tran, Lili Du, Jérôme Lemonnier

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.
Enora Laas, Anne-Sophie Hamy, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.
Séverine Guiu, Judith Balmaña, Pablo Lemercier, Philippe Follana, Anthony Gonçalves, Jérôme Lemonnier

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.
François-Clément Bidard, Grégoire Gessain, Thomas Bachelot, Lucie Frechin, Anne Vincent-Salomon, Jérôme Lemonnier

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis